Part III: Computational Modeling Tools – Evaluating the Safety and Performance of Blood-Contacting Medical Devices.
- Shared screen with speaker view

01:17:22
Is there anyway for someone in the public to track who has used a given regulatory science tool? For example, could someone in the public identify the 30+ stakeholders who used the validation data for nozzles and pumps in their regulatory submissions?

01:35:22
Could you please share with us the validation technique?

01:37:19
Hey brent! Can you skip to the last slide? sorry!

01:39:57
Mostafa Ghoreyshi (You): Thank you for the talks. How do you evaluate submissions that do not have simulation data vs. the ones that do? Is that going to affect your evaluation in a positive or nevarive way?

01:40:14
Negative* way

01:42:53
Contact the Division of Industry and Consumer Education (DICE)https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/contact-us-division-industry-and-consumer-education-dice

01:43:03
Could you please comment on the best practices for a Q-Sub process to obtain feedback on planned modeling & credibility activities to support an FDA submission.

01:43:32
FDA Catalog of Regulatory Science Tools to Help Assess New Medical Deviceshttps://www.fda.gov/medical-devices/science-and-research-medical-devices/catalog-regulatory-science-tools-help-assess-new-medical-devices

01:45:48
How do you evaluate submissions that do not have simulation data vs. the ones that do? Is that going to affect your evaluation in a positive or negative way?

01:47:41
nhlbi_sbir@mail.nih.gov